相关实验视频
Updated: Feb 5, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
合成分数II与脂质特征,血清尿酸水平和多种冠状动脉疾病患者的糖尿病病的关联
Vedran Đambić1, Ivica Bošnjak2, Dijana Dumančić
1Hyperbaric Medicine Unit, Slavonia Polyclinic, Osijek, Croatia.
合成得分II (SSII) 预测了多血管冠状动脉疾病 (CAD) 的死亡率. 较高的SS II分数与糖尿病和高尿素血症相关,但令人惊的是,高HDL和低LDL水平也是如此.
科学领域:
- 心脏病学 心脏病学
- 临床风险评估临床风险评估
背景情况:
- 综合得分II (SSII) 是一个验证的工具,用于预测多血管冠状动脉疾病 (CAD) 患者的死亡率.
- 了解影响SS II的因素对于优化治疗策略至关重要,包括穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG).
研究的目的:
- 在CAD患者中调查脂质样本 (HDL,LDL,总胆固醇,甘油三),尿酸水平和糖尿病状况与SS II值之间的相关性.
- 确定传统动脉样硬化风险因素是否与较高的SS II分数有关.
主要方法:
- 分析了72名CAD患者的队列.
- 通过在线计算器计算SS II.
- 包括曼·惠特尼U和沙皮罗-威尔克测试在内的统计分析被用来评估临床参数和SS II之间的相关性.
主要成果:
- 在高高的HDL水平和PCI的SS II之间观察到显著的正相关性.
- 较低的LDL水平与CABG的SS II增加有关.
- 高尿路血和糖尿病状况与PCI的SS II显著正相关.
- 总胆固醇和甘油三与SS II PCI或SS II CABG没有发现显著的相关性.
结论:
- 二级神经硬化与已确定的动脉样硬化风险因素 (如糖尿病和高尿血) 相关.
- 意想不到的是,这项研究发现了SS II和脂质配置文件之间的相关性,特别是该患者队列中的高HDL和低LDL水平.
- 这些发现表明影响SS II的因素的复杂相互作用,并强调需要进一步研究.
更多相关视频
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
10:48Electrochemical Preparation of Poly3,4-Ethylenedioxythiophene Layers on Gold Microelectrodes for Uric Acid-Sensing Applications
Published on: July 28, 2021
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Profile Leveling and Cross Sections